Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds
Launched by CONTURA · Dec 4, 2006
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • interested on soft tissue augmentation for the nasolabial folds
- • moderate to severe nasolabial fold
- Exclusion Criteria:
- • sensitivity to anesthetics
- • allergy to hyaluronic acid
- • previous treatment with permanent fillers in the treated area
- • recent previous aesthetic procedure in the treatment area
- • infected skin areas or autoimmune diseases affecting the skin
About Contura
Contura is a leading clinical trial sponsor dedicated to advancing innovative medical solutions through rigorous research and development. With a focus on enhancing patient outcomes, Contura specializes in conducting clinical trials across a range of therapeutic areas, including oncology, neurology, and rare diseases. The organization is committed to maintaining the highest standards of ethical practice and regulatory compliance, ensuring the safety and well-being of participants while generating valuable data to support the development of new therapies. By leveraging cutting-edge technology and a collaborative approach, Contura aims to accelerate the translation of scientific discoveries into effective treatments for patients in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
White Plains, New York, United States
Patients applied
Trial Officials
Silvia Codony
Study Director
Contura
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials